COMMUNIQUÉS West-GlobeNewswire

ALK's Board of Directors to nominate Vincent Warnery as new member of the Board
15/01/2019
The Board of Directors of ALK-Abelló A/S ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) is pleased to announce that it will nominate Vincent Warnery as an independent member of the Board of ALK-Abelló A/S at the Annual [...]
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea® product information
15/01/2019
Efficacy data from sub-group analysis for Apealea show significant advantage with regards to progression free survival in patients with first relapse. Oasmia Pharmaceutical AB (NASDAQ: OASM) AB today announce that the [...]
AroCell signs distribution agreement with Gongyingshi in China for AroCell TK 210 ELISA
15/01/2019
AroCell AB (publ) announced today that a distribution agreement has been signed with the Beijing based company Gongyingshi for the promotion and distribution of the AroCell TK 210™ ELISA in China. The pharmaceutical and [...]
Achim von Leoprechting promoted to become CEO of Tecan after retirement of David Martyr
15/01/2019
Männedorf, Switzerland, January 15, 2019 - The Tecan Group (SIX Swiss Exchange: TECN) announced today the retirement of Tecan CEO Dr David Martyr after 6 1/2 years at the helm of the company. The Board of Directors has [...]
Bio-Path Holdings, Inc. Announces Pricing of Public Offering of Common Stock
15/01/2019
HOUSTON, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio [...]
ASLAN Pharmaceuticals to Present Positive varlitinib Data in First-Line Biliary Tract Cancer in Combination With Chemotherapy at ASCO GI
14/01/2019
Objective Response Rate of 60% and Disease Control Rate of 100% observed in 300mg dose cohort Data demonstrate increased activity of varlitinib in combination with gem/cis compared to standard of care SINGAPORE, Jan. 15 [...]
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
14/01/2019
RUTHERFORD, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
14/01/2019
NEW YORK, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) , a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology [...]
CFN Media to Film Interviews at the Benzinga Cannabis Capital Conference
14/01/2019
Seattle, Washington, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”, “CannabisFN”) , the leading agency and financial media network dedicated to the worldwide cannabis industry, today [...]
BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma
14/01/2019
CAMBRIDGE, Mass. and BEIJING, China, Jan. 14, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results
14/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report fourth quarter and full [...]
HTG Molecular Announces Executive Transition Plan
14/01/2019
Chief Executive Officer TJ Johnson to assume role of Executive Chairman at the end of first quarter 2019 John Lubniewski, President and Chief Operating Officer, appointed as successor TUCSON, Ariz., Jan. 14, 2019 (GLOBE [...]
Lexington Regional Health Center, Cerner Work to Improve Health Care Outcomes for Community
14/01/2019
LEXINGTON, Neb., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Lexington Regional Health Center (LRHC), a rural critical access hospital in Central Nebraska, has teamed up with Cerner, a global leader in health care technology, to [...]
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
14/01/2019
HOUSTON, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio [...]
Genesis HealthCare Raises Over $165,000 as a National Team for Alzheimer’s Association Walk to End Alzheimer’s®
14/01/2019
Walk to End Alzheimer’s is Largest Fundraiser Dedicated to Alzheimer’s Care, Support and Research KENNETT SQUARE, Pa., Jan. 14, 2019 (GLOBE NEWSWIRE) -- More than 140 teams from Genesis HealthCare joined the Alzheimer’s [...]
Tauriga Sciences Inc. Reaches Agreement to Extinguish $75,000 Contingent Liability
14/01/2019
New York, NY, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Ossur Hf : Transactions in relation to share buyback program
14/01/2019
Announcement no. 02/2019 14 January 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Research Published in Nature Medicine Demonstrates the Immunological Effects of Tomivosertib, Including Inhibiting Production of Checkpoint Protein PD-L1 and Increasing T Cell Infiltration into Tumors
14/01/2019
SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced publication in the peer [...]
Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization Programs
14/01/2019
NEW YORK and MELBOURNE, Australia, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; Nasdaq: MESO) today announced that it has drawn down a further US$15 million from its US$75 million, non-dilutive, four- [...]

Pages